✦ LIBER ✦

Viral delivery of GDNF for Parkinson's disease

✍ Scribed by Rebecca Love

Book ID: 114407972
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 54 KB
Volume: 4
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(05)70032-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained delivery of GDNF: towards a tr

Sustained delivery of GDNF: towards a treatment for Parkinson’s disease

✍ Anne D Zurn; Hans R Widmer; Patrick Aebischer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 910 KB

Effective GDNF brain delivery using micr

Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease

✍ E. Garbayo; C.N. Montero-Menei; E. Ansorena; J.L. Lanciego; M.S. Aymerich; M.J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Localized striatal delivery of GDNF as a

Localized striatal delivery of GDNF as a treatment for Parkinson disease

✍ Kirik, Deniz; Georgievska, Biljana; Björklund, Anders 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 424 KB

GDNF trial: promising results for Parkin

GDNF trial: promising results for Parkinson's disease

✍ James Butcher 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 48 KB

Crossroads in GDNF therapy for Parkinson

Crossroads in GDNF therapy for Parkinson's disease

✍ Todd B. Sherer; Brian K. Fiske; Clive N. Svendsen; Anthony E. Lang; J. William L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract The development of a neuroprotective or neuroregenerative therapy for Parkinson's disease (PD) would be a major therapeutic advance. Unfortunately, results from a recent controlled clinical study delivering the neurotrophic factor, glial‐derived neurotrophic factor (GDNF), directly into

Continuing trials of GDNF in Parkinson's

Continuing trials of GDNF in Parkinson's disease

✍ Roger A Barker 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 40 KB